Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to identify folate receptors in brain tumours. The identification of folate receptors and its potential application in brain tumours is a fresh and significant scientific breakthrough.
To detect folate receptors in brain tumours, folate-based radiopharmaceuticals can be utilised in positron emission tomography (PET) imaging. The identification of folate receptors and their possible application in brain tumours is a novel and major development in the science.